| NCT ID | NCT07099027 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Royal College of Surgeons, Ireland |
| Condition | Non-Small Cell Lung Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 2,183 participants |
| Start Date | 2025-05-19 |
| Primary Completion | 2026-02-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 2,183 participants in total. It began in 2025-05-19 with a primary completion date of 2026-02-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to test if it is feasible to introduce lung cancer screening in Ireland. People within a certain age group, who smoke or who smoked in the past, are at a greater risk of developing lung cancer. They can also develop chronic lung conditions that can affect their long-term health. In Ireland, about 2,690 people are diagnosed with Lung Cancer every year. Unfortunately, 2 out of every 3 people diagnosed with lung cancer die per year. The goal of this study is to try to screen for lung cancer in people before they have symptoms associated with the disease. We aim to do this by selecting people based on their age, whether they have smoked in the past or currently smoke as well as other relevant factors. People who take part in this study will have an assessment of how their lungs work and a low-dose CT scan. This is called a lung health check. The goal of the low-dose CT scan is to pick up lung cancer before it becomes symptomatic, and at an earlier stage. This scan uses a very low dose of radiation. Unfortunately, without early detection, such as is the goal of this trial, 8 out of 10 people who go on to develop lung cancer will have advanced lung cancer when it is discovered, where outcomes tend to be poor. The earlier detection of lung cancer has a greater potential for treatment. Current international recommendations suggest carrying out these scans in the community rather than in a hospital. Therefore, we aim to deliver these lung health checks using a mobile unit in the community. This study aims to test if we will successfully pick up lung cancer earlier by doing community-based 'lung health check's using mobile units in North Dublin and the North East, among people of a certain age and smoking history.
Eligibility Criteria
Inclusion Criteria: 1. 55 - 74 years of age 2. Current or former smokers * Current: \>100 cigarettes in lifetime and/or currently tobacco smoking * Former: \>100 cigarettes in lifetime and/or no tobacco smoking \>= 28 days 3. Referred from a GP for the LHC pilot 4. PLCOM2012 ≥ 1.51% or LLPv2 ≥2.5% (Lung Cancer Risk Scores) * Prostate Lung Cancer Colorectal Ovarian (PLCO) \& Liverpool Lung Project Version 2 (LLPv2) Exclusion Criteria: 1. Participant-reported history of chest CT in the last 12 months 2. Inability to undergo non-contrast CT (e.g. \>200 kg body weight, inability to lie flat) 3. Participant reported known diagnosis of other advanced stage cancers 4. Participant reported diagnosis of lung cancer of any stage in the last 5 years 5. Likely non-compliance with study procedures, as determined by the participant i) Unable to provide informed consent ii) Inability to attend study visits 6. Nursing home residents -
Contact & Investigator
Jarushka Naidoo, MD
PRINCIPAL INVESTIGATOR
Beaumont RCSI Cancer Centre
Frequently Asked Questions
Who can join the NCT07099027 clinical trial?
This trial is open to participants of all sexes, aged 55 Years or older, up to 74 Years, studying Non-Small Cell Lung Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07099027 currently recruiting?
Yes, NCT07099027 is actively recruiting participants. Contact the research team at lunghealthcheck@beaumont.ie for enrollment information.
Where is the NCT07099027 trial being conducted?
This trial is being conducted at Dublin, Ireland.
Who is sponsoring the NCT07099027 clinical trial?
NCT07099027 is sponsored by Royal College of Surgeons, Ireland. The principal investigator is Jarushka Naidoo, MD at Beaumont RCSI Cancer Centre. The trial plans to enroll 2,183 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.